Vimarsana
Biggest News Aggregation in the World

Data Exclusivity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Exclusivity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Exclusivity Today - Breaking & Trending Today

Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office - Vimarsana News

Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office

Novel Composition of MDMA Enantiomers leading to next-generation MDMA possibilitiesTORONTO, March 27, 2024 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the research,...

PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development - Pharmala Biotech Hldgs (OTC:MDXXF) - Vimarsana News

PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development - Pharmala Biotech Hldgs (OTC:MDXXF)

generic drug industry: India rejects European FTA bloc's 'data exclusivity' demand to protect generic drug firms' interest - Vimarsana News

generic drug industry: India rejects European FTA bloc's 'data exclusivity' demand to protect generic drug firms' interest

India rejects EFTA's demand for 'data exclusivity' provision, protecting the generic drug industry. Secretary Barthwal emphasizes India's support for the industry. Exclusivity is beyond TRIPS agreement. EFTA has 29 FTAs with 40 partner countries, including Canada, Chile, China, Mexico, and Korea.